v3.22.2.2
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
shares in Thousands, $ in Thousands
Total
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Class A and Class B Common Stock
Class A and Class B Common Stock
Shares, beginning of period (in shares) at Jan. 31, 2021 167,058,113        
Balance, beginning of period at Jan. 31, 2021 $ 621,139        
Increase (Decrease) in Temporary Equity [Roll Forward]          
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares) (167,058,113)        
Conversion of redeemable convertible preferred stock to common stock upon initial public offering $ (621,139)        
Shares, end of period (in shares) at Jul. 31, 2021 0        
Balance, end of period at Jul. 31, 2021 $ 0        
Shares, beginning of period (in shares) at Jan. 31, 2021         39,242,316
Balance, beginning of period at Jan. 31, 2021 (320,536) $ 29,869 $ 165 $ (350,572) $ 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)         169,787,200
Conversion of redeemable convertible preferred stock to common stock upon initial public offering 621,139 621,129     $ 10
Issuance of common stock upon initial public offering and private placement, net of underwriting discounts and commissions (in shares)         41,678,568
Issuance of common stock upon initial public offering and private placement, net of underwriting discounts and commissions 1,380,960 1,380,956     $ 4
Issuance of common stock upon exercise of stock options (in shares)         4,625,342
Issuance of common stock upon exercise of options 5,827 5,827      
Vesting of early exercised stock options 544        
Issuance of common stock upon exercise of warrants (in shares)         940,953
Vesting of early exercised stock options 554 554      
Issuance of common stock and awards assumed in connection with acquisition (in shares)         7,277,214
Issuance of common stock assumed in connection with acquisition 120,319 120,318     $ 1
Issuance of restricted stock awards (in shares)         1,315,099
Stock-based compensation 37,712 37,712      
Issuance of stock for services provided (in shares)         20,000
Issuance of restricted stock for services provided 500 500      
Other comprehensive income (loss) 0        
Foreign currency translation adjustments 290   290    
Net loss (130,797)     (130,797)  
Shares, end of period (in shares) at Jul. 31, 2021         264,886,692
Balance, end of period at Jul. 31, 2021 $ 1,715,968 2,196,865 455 (481,369) $ 17
Shares, beginning of period (in shares) at Apr. 30, 2021 167,058,113        
Balance, beginning of period at Apr. 30, 2021 $ 621,139        
Increase (Decrease) in Temporary Equity [Roll Forward]          
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares) (167,058,113)        
Conversion of redeemable convertible preferred stock to common stock upon initial public offering $ (621,139)        
Shares, end of period (in shares) at Jul. 31, 2021 0        
Balance, end of period at Jul. 31, 2021 $ 0        
Shares, beginning of period (in shares) at Apr. 30, 2021         50,504,590
Balance, beginning of period at Apr. 30, 2021 (245,874) 166,974 355 (413,206) $ 3
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)         169,787,200
Conversion of redeemable convertible preferred stock to common stock upon initial public offering 621,139 621,129     $ 10
Issuance of common stock upon initial public offering and private placement, net of underwriting discounts and commissions (in shares)         41,678,568
Issuance of common stock upon initial public offering and private placement, net of underwriting discounts and commissions 1,380,960 1,380,956     $ 4
Issuance of common stock upon exercise of stock options (in shares)         1,975,381
Issuance of common stock upon exercise of options 2,617 2,617      
Issuance of common stock upon exercise of warrants (in shares)         940,953
Vesting of early exercised stock options 537 537      
Stock-based compensation 24,152 24,152      
Issuance of restricted stock for services provided 500 500      
Other comprehensive income (loss) 0        
Foreign currency translation adjustments 100   100    
Net loss (68,163)     (68,163)  
Shares, end of period (in shares) at Jul. 31, 2021         264,886,692
Balance, end of period at Jul. 31, 2021 $ 1,715,968 2,196,865 455 (481,369) $ 17
Shares, beginning of period (in shares) at Jan. 31, 2022 0        
Balance, beginning of period at Jan. 31, 2022 $ 0        
Shares, end of period (in shares) at Jul. 31, 2022 0        
Balance, end of period at Jul. 31, 2022 $ 0        
Shares, beginning of period (in shares) at Jan. 31, 2022         270,451,615
Balance, beginning of period at Jan. 31, 2022 1,650,788 2,271,980 454 (621,673) $ 27
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)         3,369,153
Issuance of common stock upon exercise of options 8,381 8,381      
Vesting of restricted stock units (in shares)         317,854
Issuance of common stock under employee purchase plan (in shares)         405,534
Issuance of common stock under employee purchase plan 8,682 8,682      
Vesting of early exercised stock options 18 18      
Issuance of common stock and awards assumed in connection with acquisition (in shares)         6,032,231
Issuance of common stock assumed in connection with acquisition 186,333 186,332     $ 1
Stock-based compensation 74,221 74,221      
Other comprehensive income (loss) (2,467)   (2,467)    
Foreign currency translation adjustments 0        
Net loss (186,140)     (186,140)  
Shares, end of period (in shares) at Jul. 31, 2022         280,576,387
Balance, end of period at Jul. 31, 2022 $ 1,739,816 2,549,614 (2,013) (807,813) $ 28
Shares, beginning of period (in shares) at Apr. 30, 2022 0        
Balance, beginning of period at Apr. 30, 2022 $ 0        
Shares, end of period (in shares) at Jul. 31, 2022 0        
Balance, end of period at Jul. 31, 2022 $ 0        
Shares, beginning of period (in shares) at Apr. 30, 2022         272,496,624
Balance, beginning of period at Apr. 30, 2022 1,597,242 2,309,505 (783) (711,507) $ 27
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)         1,350,556
Issuance of common stock upon exercise of options 3,291 3,291      
Vesting of restricted stock units (in shares)         291,442
Issuance of common stock under employee purchase plan (in shares)         405,534
Issuance of common stock under employee purchase plan 8,682 8,682      
Issuance of common stock and awards assumed in connection with acquisition (in shares)         6,032,231
Issuance of common stock assumed in connection with acquisition 186,333 186,332     $ 1
Stock-based compensation 41,804 41,804      
Other comprehensive income (loss) (1,230)   (1,230)    
Foreign currency translation adjustments 0        
Net loss (96,306)     (96,306)  
Shares, end of period (in shares) at Jul. 31, 2022         280,576,387
Balance, end of period at Jul. 31, 2022 $ 1,739,816 $ 2,549,614 $ (2,013) $ (807,813) $ 28